The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery
Abstract
Vaccines have been at the forefront of improving human health for over two centuries. The challenges faced in developing effective vaccines flow from complexities associated with the immune system and requirement of an efficient and safe adjuvant to induce a strong adaptive immune response. Development of an efficient vaccine formulation requires careful selection of a potent antigen, efficient adjuvant and route of delivery. Adjuvants are immunological agents that activate the antigen presenting cells (APCs) and elicit a strong immune response. In the past decade, the use of mesoporous silica nanoparticles (MSNs) has gained significant attention as potential delivery vehicles for various biomolecules. In this review, we aim to highlight the potential of MSNs as vaccine delivery vehicles and their ability to act as adjuvants. We have provided an overview on the latest progress on synthesis, adsorption and release kinetics and biocompatibility of MSNs as next generation antigen carriers and adjuvants. A comprehensive summary on the ability of MSNs to deliver antigens and elicit both humoral and cellular immune responses is provided. Finally, we give insight on fundamental challenges and some future prospects of these nanoparticles as adjuvants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism
Kresge, C. T., Leonowicz, M. E., Roth, W. J., Vartuli, J. C., & Beck, J. S. (1992) · Nature · doi:10.1038/359710a0 · Cited by 16,275
Controlled growth of monodisperse silica spheres in the micron size range
Stöber, W., Fink, A., & Bohn, E. (1968) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(68)90272-5 · Cited by 14,532
Triblock Copolymer Syntheses of Mesoporous Silica with Periodic 50 to 300 Angstrom Pores
Zhao, D., Feng, J., Huo, Q., Melosh, N., Fredrickson, G. H., Chmelka, B. F., & Stucky, G. D. (1998) · Science · doi:10.1126/science.279.5350.548 · Cited by 11,753
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
Silica‐Based Mesoporous Organic–Inorganic Hybrid Materials
Hoffmann, F., Cornelius, M., Morell, J., & Fröba, M. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503075 · Cited by 3,089
Hollow Micro‐/Nanostructures: Synthesis and Applications
Lou, X. W. (., Archer, L. A., & Yang, Z. (2008) · Advanced Materials · doi:10.1002/adma.200800854 · Cited by 2,992
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
Tang, F., Li, L., & Chen, D. (2012) · Advanced Materials · doi:10.1002/adma.201104763 · Cited by 2,836
Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers☆
SLOWING, I., VIVEROESCOTO, J., WU, C., & LIN, V (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.012 · Cited by 2,653
On the controllable soft-templating approach to mesoporous silicates
Wan, Y., & Zhao (2007) · Chemical Reviews · doi:10.1021/cr068020s · Cited by 2,371
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,339
A New Property of MCM-41: Drug Delivery System
Vallet-Regi, M., Rámila, A., del Real, R. P., & Pérez-Pariente, J. (2001) · Chemistry of Materials · doi:10.1021/cm0011559 · Cited by 2,182
Mesoporous silica nanoparticles in biomedical applications
Li, Z., Barnes, J. C., Bosoy, A., Stoddart, J. F., & Zink, J. I. (2012) · Chemical Society Reviews · doi:10.1039/c1cs15246g · Cited by 1,907
Yanagisawa, T., Shimizu, T., Kuroda, K., & Kato, C. (1990) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.63.988 · Cited by 1,783
Mesoporous silica nanoparticles for drug delivery and biosensing applications
Slowing, I. I., Trewyn, B. G., Giri, S., & Lin, V. S. ‐. (2007) · Advanced Functional Materials · doi:10.1002/adfm.200601191 · Cited by 1,699
INDUCTION OF TH1 AND TH2 CD4+T CELL RESPONSES:The Alternative Approaches
Constant, S. L., & Bottomly, K. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.297 · Cited by 1,459
Lu, J., Liong, M., Li, Z., Zink, J. I., & Tamanoi, F. (2010) · Small · doi:10.1002/smll.201000538 · Cited by 1,074
Size Effect on Cell Uptake in Well‐Suspended, Uniform Mesoporous Silica Nanoparticles
Lu, F., Wu, S., Hung, Y., & Mou, C. (2009) · Small · doi:10.1002/smll.200900005 · Cited by 1,041
Mesoporous Silica Nanoparticles as a Delivery System for Hydrophobic Anticancer Drugs
Lu, J., Liong, M., Zink, J. I., & Tamanoi, F. (2007) · Small · doi:10.1002/smll.200700005 · Cited by 1,012
Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery
Vivero‐Escoto, J. L., Slowing, I. I., Trewyn, B. G., & Lin, V. S. ‐. (2010) · Small · doi:10.1002/smll.200901789 · Cited by 998
Giri, S., Trewyn, B. G., Stellmaker, M. P., & Lin, V. S. ‐. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200501819 · Cited by 997
Xia, T., Kovochich, M., Liong, M., Meng, H., Kabehie, S., George, S., Zink, J. I., & Nel, A. E. (2009) · ACS Nano · doi:10.1021/nn900918w · Cited by 933
Meng, H., Liong, M., Xia, T., Li, Z., Ji, Z., Zink, J. I., & Nel, A. E. (2010) · ACS Nano · doi:10.1021/nn100690m · Cited by 902
Slowing, I., Trewyn, B. G., & Lin, V. S.-Y. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0645943 · Cited by 846
Lin, Y.-S., & Haynes, C. L. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910846q · Cited by 837
Mesoporous Silica Nanoparticles for Intracellular Delivery of Membrane-Impermeable Proteins
Slowing, I. I., Trewyn, B. G., & Lin, V. S.-Y. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0719780 · Cited by 795
Zhao, Y., Trewyn, B. G., Slowing, I. I., & Lin, V. S.-Y. (2009) · Journal of the American Chemical Society · doi:10.1021/ja901831u · Cited by 771
Silica and titanium dioxide nanoparticles cause pregnancy complications in mice
Yamashita, K., Yoshioka, Y., Higashisaka, K., Mimura, K., Morishita, Y., Nozaki, M., Yoshida, T., Ogura, T., Nabeshi, H., Nagano, K., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.41 · Cited by 738
He, Q., & Shi, J. (2011) · Journal of Materials Chemistry · doi:10.1039/c0jm03851b · Cited by 691
Dilute Solution Routes to Various Controllable Morphologies of MCM-41 Silica with a Basic Medium
Cai, Q., Luo, Z.-S., Pang, W.-Q., Fan, Y.-W., Chen, X.-H., & Cui, F.-Z. (2001) · Chemistry of Materials · doi:10.1021/cm990661z · Cited by 679
Proteins in Mesoporous Silicates
Hudson, S., Cooney, J., & Magner, E. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705238 · Cited by 663
He, Q., Zhang, Z., Gao, F., Li, Y., & Shi, J. (2011) · Small · doi:10.1002/smll.201001459 · Cited by 661
Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma
Benezra, M., Penate-Medina, O., Zanzonico, P. B., Schaer, D., Ow, H., Burns, A., DeStanchina, E., Longo, V., Herz, E., Iyer, S., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45600 · Cited by 645
New horizons in adjuvants for vaccine development
Reed, S. G., Bertholet, S., Coler, R. N., & Friede, M. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.09.006 · Cited by 618
Muhammad, F., Guo, M., Qi, W., Sun, F., Wang, A., Guo, Y., & Zhu, G. (2011) · Journal of the American Chemical Society · doi:10.1021/ja200328s · Cited by 603
Ishida, T., Ichihara, M., Wang, X., Yamamoto, K., Kimura, J., Majima, E., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.005 · Cited by 557
New horizons in adjuvants for vaccine development
Reed, S. G., Tomai, M., & Gale, M. J. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.08.008 · Cited by 554
Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers
Popat, A., Hartono, S. B., Stahr, F., Liu, J., Qiao, S. Z., & Qing (Max) Lu, G. (2011) · Nanoscale · doi:10.1039/c1nr10224a · Cited by 548
Self-citationThe biocompatibility of mesoporous silicates
Hudson, S. P., Padera, R. F., Langer, R., & Kohane, D. S. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.07.007 · Cited by 538
He, Q., Zhang, J., Shi, J., Zhu, Z., Zhang, L., Bu, W., Guo, L., & Chen, Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.10.046 · Cited by 502
Fluorescent Silica Nanoparticles with Efficient Urinary Excretion for Nanomedicine
Burns, A. A., Vider, J., Ow, H., Herz, E., Penate-Medina, O., Baumgart, M., Larson, S. M., Wiesner, U., & Bradbury, M. (2009) · Nano Letters · doi:10.1021/nl803405h · Cited by 474
Advances in saponin-based adjuvants
Sun, H.-X., Xie, Y., & Ye, Y.-P. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.091 · Cited by 471
Manzano, M., Aina, V., Areán, C. O., Balas, F., Cauda, V., Colilla, M., Delgado, M. R., & Vallet-Regí, M. (2008) · Chemical Engineering Journal · doi:10.1016/j.cej.2007.07.078 · Cited by 422
New adjuvants for human vaccines
Mbow, M. L., De Gregorio, E., Valiante, N. M., & Rappuoli, R. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.04.004 · Cited by 406
Stealth PLA-PEG nanoparticles as protein carriers for nasal administration
Tobío, M., Gref, R., Sánchez, A., Langer, R., & Alonso, M. J. (1998) · Pharmaceutical Research · doi:10.1023/a:1011922819926 · Cited by 402
pH- and Photo-Switched Release of Guest Molecules from Mesoporous Silica Supports
Aznar, E., Marcos, M. D., Martínez-Máñez, R., Sancenón, F., Soto, J., Amorós, P., & Guillem, C. (2009) · Journal of the American Chemical Society · doi:10.1021/ja810011p · Cited by 387
Kim, M.-H., Na, H.-K., Kim, Y.-K., Ryoo, S.-R., Cho, H. S., Lee, K. E., Jeon, H., Ryoo, R., & Min, D.-H. (2011) · ACS Nano · doi:10.1021/nn103130q · Cited by 364
Kneuer, C., Sameti, M., Bakowsky, U., Schiestel, T., Schirra, H., Schmidt, H., & Lehr, C.-M. (2000) · Bioconjugate Chemistry · doi:10.1021/bc0000637 · Cited by 359
Mechanisms of stimulation of the immune response by aluminum adjuvants
HogenEsch, H. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00169-x · Cited by 354
Mesoporous Silicate Sequestration and Release of Proteins
Han, Y.-J., Stucky, G. D., & Butler, A. (1999) · Journal of the American Chemical Society · doi:10.1021/ja992138r · Cited by 351
In Vivo Study of Biodistribution and Urinary Excretion of Surface-Modified Silica Nanoparticles
He, X., Nie, H., Wang, K., Tan, W., Wu, X., & Zhang, P. (2008) · Analytical Chemistry · doi:10.1021/ac801882g · Cited by 348
pH Clock-Operated Mechanized Nanoparticles
Angelos, S., Khashab, N. M., Yang, Y.-W., Trabolsi, A., Khatib, H. A., Stoddart, J. F., & Zink, J. I. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9010157 · Cited by 345
Enzyme immobilisation using SBA-15 mesoporous molecular sieves with functionalised surfaces
Yiu, H. H. P., Wright, P. A., & Botting, N. P. (2001) · Journal of Molecular Catalysis B Enzymatic · doi:10.1016/s1381-1177(01)00011-x · Cited by 337
A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles
Popat, A., Liu, J., Lu, G. Q. (., & Qiao, S. Z. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm30501a · Cited by 321
Self-citationBenjamini, E., & Leskowitz, S. S. (1988) · Andalas University Repository (Andalas University) · Cited by 315
Sensitization and Antibody Formation after Injection of Tubercle Bacilli and Paraffin Oil.
Freund, J., Casals, J., & Hosmer, E. P. (1937) · Experimental Biology and Medicine · doi:10.3181/00379727-37-9625 · Cited by 311
Hollow mesoporous silica nanoparticles for intracellular delivery of fluorescent dye
Guo, H., Qian, H., Sun, S., Sun, D., Yin, H., Cai, X., Liu, Z., Wu, J., Jiang, T., & Liu, X. (2011) · Chemistry Central Journal · doi:10.1186/1752-153x-5-1 · Cited by 299
Trewyn, B. G., Nieweg, J. A., Zhao, Y., & Lin, V. S.-Y. (2008) · Chemical Engineering Journal · doi:10.1016/j.cej.2007.09.045 · Cited by 275
Mesoporous Silica Particles Induce Size Dependent Effects on Human Dendritic Cells
Vallhov, H., Gabrielsson, S., Strømme, M., Scheynius, A., & Garcia-Bennett, A. E. (2007) · Nano Letters · doi:10.1021/nl0714785 · Cited by 270
Hartono, S. B., Gu, W., Kleitz, F., Liu, J., He, L., Middelberg, A. P. J., Yu, C., Lu, G. Q. (., & Qiao, S. Z. (2012) · ACS Nano · doi:10.1021/nn2039643 · Cited by 264
Self-citationNanoparticles and microparticles as vaccine-delivery systems
Singh, M., Chakrapani, A., & O’Hagan, D. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.797 · Cited by 259
Enzyme‐Responsive Controlled Release Using Mesoporous Silica Supports Capped with Lactose
Bernardos, A., Aznar, E., Marcos, M. D., Martínez‐Máñez, R., Sancenón, F., Soto, J., Barat, J. M., & Amorós, P. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900880 · Cited by 250
Cytotoxicity of mesoporous silica nanomaterials
Di Pasqua, A. J., Sharma, K. K., Shi, Y.-L., Toms, B. B., Ouellette, W., Dabrowiak, J. C., & Asefa, T. (2008) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2007.12.028 · Cited by 227
Nanoparticle Delivery Systems in Cancer Vaccines
Krishnamachari, Y., Geary, S. M., Lemke, C. D., & Salem, A. K. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0241-4 · Cited by 219
Wen, Z.-S., Xu, Y.-L., Zou, X.-T., & Xu, Z.-R. (2011) · Marine Drugs · doi:10.3390/md9061038 · Cited by 215
Coll, C., Mondragón, L., Martínez‐Máñez, R., Sancenón, F., Marcos, M. D., Soto, J., Amorós, P., & Pérez‐Payá, E. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201004133 · Cited by 211
Nanoparticles and microparticles for drug and vaccine delivery.
Kreuter, J. (1996) · Europe PMC (PubMed Central) · Cited by 204
Black, M., Trent, A., Tirrell, M., & Olive, C. (2010) · Expert Review of Vaccines · doi:10.1586/erv.09.160 · Cited by 203
Oxidative stress of silica nanoparticles in human bronchial epithelial cell, Beas-2B
Eom, H.-J., & Choi, J. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.07.010 · Cited by 188
Gary-Bobo, M., Hocine, O., Brevet, D., Maynadier, M., Raehm, L., Richeter, S., Charasson, V., Loock, B., Morère, A., Maillard, P., et al. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.11.045 · Cited by 186
Lee, S., Yun, H.-S., & Kim, S.-H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.042 · Cited by 182
Jung, T., Kamm, W., Breitenbach, A., Hungerer, K.-D., Hundt, E., & Kissel, T. (2001) · Pharmaceutical Research · doi:10.1023/a:1011063232257 · Cited by 177
Functional Assessment of Metal Oxide Nanoparticle Toxicity in Immune Cells
Maurer-Jones, M. A., Lin, Y.-S., & Haynes, C. L. (2010) · ACS Nano · doi:10.1021/nn9018834 · Cited by 171
Implication of oxidative stress in size-dependent toxicity of silica nanoparticles in kidney cells
Passagne, I., Morille, M., Rousset, M., Pujalté, I., & L’Azou, B. (2012) · Toxicology · doi:10.1016/j.tox.2012.05.010 · Cited by 166
Interaction of dendritic cells with biomaterials
Babensee, J. E. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.013 · Cited by 156
Foged, C. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.68 · Cited by 154
Chwalek, M., Lalun, N., Bobichon, H., Plé, K., & Voutquenne‐Nazabadioko, L. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.05.004 · Cited by 152
QS-21: a water-soluble triterpene glycoside adjuvant
Kensil, C. R., & Kammer, R. B. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.9.1475 · Cited by 152
Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene delivery
Sameti, M., Bohr, G., Kumar, M. N. V. R., Kneuer, C., Bakowsky, U., Nacken, M., Schmidt, H. K., & Lehr, C. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00380-6 · Cited by 147
Protein drug oral delivery: The recent progress
Lee, H. J. (2002) · Archives of Pharmacal Research · doi:10.1007/bf02976925 · Cited by 143
Nanoparticles as carriers for nasal vaccine delivery
Köping‐Höggård, M., Sánchez, A., & Alonso, M. J. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.2.185 · Cited by 143
Mesoporosity and Functional Group Dependent Endocytosis and Cytotoxicity of Silica Nanomaterials
Tao, Z., Toms, B. B., Goodisman, J., & Asefa, T. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900276u · Cited by 142
Hartono, S. B., Qiao, S., Jack, K. S., Ladewig, B. P., Hao, Z., & Lu, G. Q. (2009) · Langmuir · doi:10.1021/la900023p · Cited by 140
Wang, T., Jiang, H., Zhao, Q., Wang, S., Zou, M., & Cheng, G. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.06.028 · Cited by 140
Biozzi, G., Mouton, D., Stiffel, C., & Bouthillier, Y. (1984) · Advances in immunology · doi:10.1016/s0065-2776(08)60902-5 · Cited by 139
Huang, D., Chung, T.-H., Hung, Y., Lu, F., Wu, S., Mou, C., Yao, M., & Chen, Y. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.04.009 · Cited by 137
pH-Controllable drug release using hydrogel encapsulated mesoporous silica
Song, S., Hidajat, K., & Kawi, S. (2007) · Chemical Communications · doi:10.1039/b707626f · Cited by 134
Saponin-adjuvanted particulate vaccines for clinical use
Skene, C. D., & SUTTON, P. R. N. (2006) · Methods · doi:10.1016/j.ymeth.2006.05.019 · Cited by 133
Peptide-Based Subunit Nanovaccines
Skwarczyński, M., & Tóth, I. (2011) · Current Drug Delivery · doi:10.2174/156720111795256192 · Cited by 130
Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles
Thomas, M., Slipper, I. J., Walunj, A., Jain, A., Favretto, M. E., Kallinteri, P., & Douroumis, D. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.12.023 · Cited by 128
Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15
Carvalho, L. V., Ruiz, R. C., Scaramuzzi, K., Marengo, E. B., de Matos, J. R., Tambourgi, D. V., Fantini, M. C. D. A., & Sant’Anna, O. A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.087 · Cited by 126
Zhu, Y., Meng, W., Gao, H., & Hanagata, N. (2011) · The Journal of Physical Chemistry C · doi:10.1021/jp203454g · Cited by 125
Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes
Fisichella, M., Dabboue, H., Bhattacharyya, S., Saboungi, M., Salvetat, J., Hévor, T., & Guérin, M. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.02.007 · Cited by 125
Adlakha-Hutcheon, G., Bally, M. B., Shew, C. R., & Madden, T. D. (1999) · Nature Biotechnology · doi:10.1038/11710 · Cited by 121
Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells
Heikkilä, T., Santos, H. A., Kumar, N., Murzin, D. Y., Salonen, J., Laaksonen, T., Peltonen, L., Hirvonen, J. J., & Lehto, V. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.12.006 · Cited by 105
Toxicity and Genotoxicity of Nano-SiO2 on Human Epithelial Intestinal HT-29 Cell Line
Sergent, J., Paget, V., & Chevillard, S. (2012) · The Annals of Occupational Hygiene · doi:10.1093/annhyg/mes005 · Cited by 105
Moghimi, S. M. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00204-5 · Cited by 103
Nanoparticles as Protein and Gene Carriers to Mucosal Surfaces
de la Fuente, M., Csaba, N., García-Fuentes, M., & Alonso, M. J. (2008) · Nanomedicine · doi:10.2217/17435889.3.6.845 · Cited by 93
A Practical Approach to the use of Nanoparticles for Vaccine Delivery
Wendorf, J. R., Singh, M., Chesko, J., Kazzaz, J., Soewanan, E., Ugozzoli, M., & O’Hagan, D. T. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20728 · Cited by 91
Guo, H., Feng, X.-M., Sun, S., Wei, Y., Sun, D., Liu, X., Liu, Z., Luo, J., & Yin, H. (2012) · Virology Journal · doi:10.1186/1743-422x-9-108 · Cited by 88
Immunotoxicity derived from manipulating leukocytes with lipid-based nanoparticles
Peer, D. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.06.013 · Cited by 88
In vivo induction of type 1 and 2 immune responses against protein antigens
Comoy, E. E. (1997) · International Immunology · doi:10.1093/intimm/9.4.523 · Cited by 87
Yagüe, C., Moros, M., Grazú, V., Arruebo, M., & Santamarı́a, J. (2007) · Chemical Engineering Journal · doi:10.1016/j.cej.2007.07.088 · Cited by 86
Vaccine hypersensitivity - update and overview
Fritsche, P. (2010) · Swiss Medical Weekly · doi:10.4414/smw.2010.12980 · Cited by 77
Kammer, A. R., Amacker, M., Rasi, S., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.052 · Cited by 66
Mesoporous silica nanoparticles as a compound delivery system in zebrafish embryos
Sharif, F., Porta, Meijer, A. H., Kros, A., & Richardson, R. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s26547 · Cited by 64
pH-responsive mitoxantrone (MX) delivery using mesoporous silica nanoparticles (MSN)
Ma, Y., Zhou, L., Zheng, H., Xing, L., Li, C., Cui, J.-H., & Che, S. (2011) · Journal of Materials Chemistry · doi:10.1039/c1jm10750j · Cited by 58
Intracellular protein delivery by hollow mesoporous silica capsules with a large surface hole
Lim, J.-S., Lee, K., Choi, J.-N., Hwang, Y., Yun, M.-Y., Kim, H.-J., Won, Y. S., Kim, S., Kwon, H., & Huh, S. (2012) · Nanotechnology · doi:10.1088/0957-4484/23/8/085101 · Cited by 52
Kar, U. K., Jiang, J., Champion, C. I., Salehi, S., Srivastava, M. K., Sharma, S. P., Rabizadeh, S., Niazi, K., Kickhoefer, V. A., Rome, L. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038553 · Cited by 43
Nano Dot Technology Enters Clinical Trials
Friedman, R. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr400 · Cited by 40
Recent Advances in the Rational Design of silica-based Nanoparticles for Gene Therapy
Niu, Y., Popat, A., Yu, M., Karmakar, S., Gu, W., & Yu, C. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.98 · Cited by 38
Self-citationDhur, A., Galan, P., Preziosi, P., & Herçberg, S. (1991) · Journal of Nutrition · doi:10.1093/jn/121.9.1418 · Cited by 37
Guo, H., Hao, R., Qian, H., Sun, S., Sun, D., Yin, H., Liu, Z., & Liu, X. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4042-z · Cited by 25
Cited by
Vaccine adjuvants: mechanisms and platforms
Zhao, T., Cai, Y., Jiang, Y., He, X., Wei, Y., Yu, Y., & Tian, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01557-7 · Cited by 1,020
Zhao, L., Seth, A., Wibowo, N., Zhao, C.-X., Mitter, N., Yu, C., & Middelberg, A. P. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.069 · Cited by 919
Self-citationCroissant, J. G., Fatieiev, Y., Almalik, A., & Khashab, N. M. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700831 · Cited by 594
Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
Vallet-Regí, M., Schüth, F., Lozano, D., Colilla, M., & Manzano, M. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00659b · Cited by 507
DNA Vaccines—How Far From Clinical Use?
Hobernik, D., & Bros, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113605 · Cited by 457
Metadata
- Authors
- Mody, K. T., Popat, A., Mahony, D., Cavallaro, A. S., Yu, C., & Mitter, N.
- Venue
- Nanoscale
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2013
- Volume
- 5
- Issue
- 12
- Pages
- 5167
- ISSN
- 2040-3364 (ISSN-L)
- 2040-3372
- OpenAlex
- W1974824639
- Cited by
- 261
- References
- 114
- FWCI
- 7.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.